Walton KL - Search Results

1

Activin A-Induced Cachectic Wasting Is Attenuated by Systemic Delivery of Its Cognate Propeptide in Male Mice.

Walton KL, Chen JL, Arnold Q, Kelly E, La M, Lu L, Lovrecz G, Hagg A, Colgan TD, Qian H, Gregorevic P, Harrison CA. Walton KL, et al. Endocrinology. 2019 Oct 1;160(10):2417-2426. doi: 10.1210/en.2019-00257. Endocrinology. 2019. PMID: 31322699

2

Suppression of inhibin A biological activity by alterations in the binding site for betaglycan.

Makanji Y, Walton KL, Wilce MC, Chan KL, Robertson DM, Harrison CA. Makanji Y, et al. Among authors: walton kl. J Biol Chem. 2008 Jun 13;283(24):16743-51. doi: 10.1074/jbc.M801045200. Epub 2008 Apr 7. J Biol Chem. 2008. PMID: 18397882 Free article.

3

A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligands.

Walton KL, Makanji Y, Wilce MC, Chan KL, Robertson DM, Harrison CA. Walton KL, et al. J Biol Chem. 2009 Apr 3;284(14):9311-20. doi: 10.1074/jbc.M808763200. Epub 2009 Feb 3. J Biol Chem. 2009. PMID: 19193648 Free PMC article.

4

Inhibin B is a more potent suppressor of rat follicle-stimulating hormone release than inhibin a in vitro and in vivo.

Makanji Y, Temple-Smith PD, Walton KL, Harrison CA, Robertson DM. Makanji Y, et al. Among authors: walton kl. Endocrinology. 2009 Oct;150(10):4784-93. doi: 10.1210/en.2008-1783. Epub 2009 Jul 9. Endocrinology. 2009. PMID: 19589860

5

Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complex.

Walton KL, Makanji Y, Chen J, Wilce MC, Chan KL, Robertson DM, Harrison CA. Walton KL, et al. J Biol Chem. 2010 May 28;285(22):17029-37. doi: 10.1074/jbc.M110.110288. Epub 2010 Mar 22. J Biol Chem. 2010. PMID: 20308061 Free PMC article.

6

Hormonal regulation of sertoli cell micro-RNAs at spermiation.

Nicholls PK, Harrison CA, Walton KL, McLachlan RI, O'Donnell L, Stanton PG. Nicholls PK, et al. Among authors: walton kl. Endocrinology. 2011 Apr;152(4):1670-83. doi: 10.1210/en.2010-1341. Epub 2011 Feb 15. Endocrinology. 2011. PMID: 21325043

7

The synthesis and secretion of inhibins.

Walton KL, Makanji Y, Robertson DM, Harrison CA. Walton KL, et al. Vitam Horm. 2011;85:149-84. doi: 10.1016/B978-0-12-385961-7.00008-1. Vitam Horm. 2011. PMID: 21353880 Review.

8

Generation of a specific activin antagonist by modification of the activin A propeptide.

Makanji Y, Walton KL, Chan KL, Gregorevic P, Robertson DM, Harrison CA. Makanji Y, et al. Among authors: walton kl. Endocrinology. 2011 Oct;152(10):3758-68. doi: 10.1210/en.2011-1052. Epub 2011 Jul 12. Endocrinology. 2011. PMID: 21750050

9

New insights into the mechanisms of activin action and inhibition.

Walton KL, Makanji Y, Harrison CA. Walton KL, et al. Mol Cell Endocrinol. 2012 Aug 15;359(1-2):2-12. doi: 10.1016/j.mce.2011.06.030. Epub 2011 Jul 8. Mol Cell Endocrinol. 2012. PMID: 21763751 Review.

10

2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-β1 and activin A signalling.

Ciayadi R, Potdar M, Walton KL, Harrison CA, Kelso GF, Harris SJ, Hearn MT. Ciayadi R, et al. Among authors: walton kl. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5642-5. doi: 10.1016/j.bmcl.2010.12.120. Epub 2010 Dec 30. Bioorg Med Chem Lett. 2011. PMID: 21783359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page